Mayo Clinic, Eclipse launch Nucleus RadioPharma to speed cancer drug development


The health system and its VC partner together are investing $6 million in the new company, Nucleus RadioPharma, which will be based in Mayo's home city of Rochester, Minn.

Previous Downtown L.A. retail bounces back as consumers crave in-person shopping, report says
Next Why virtual health care should be a part of every organization’s risk strategy